Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score
- PMID: 30333160
- PMCID: PMC6260202
- DOI: 10.1212/WNL.0000000000006544
Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score
Abstract
Objective: To validate the ability of a specifically developed cognitive risk score to identify patients at risk of poststroke neurocognitive disorders (NCDs) who are eligible for a comprehensive cognitive assessment.
Methods: After assessing 404 patients (infarct 91.3%) in the Groupe de Réflexion pour l'Evaluation Cognitive VASCulaire (GRECogVASC) cross-sectional study with the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network battery 6 months after stroke, we used multivariable logistic regression and bootstrap analyses to determine factors associated with NCDs. Independent, internally validated factors were included in a cognitive risk score.
Results: Cognitive impairment was present in 170 of the 320 patients with a Rankin Scale score ≥1. The backward logistic regression selected 4 factors (≥73% of the permutations): NIH Stroke Scale score on admission ≥7 (odds ratio [OR] 2.73, 95% confidence interval [CI] 1.29-4.3, p = 0.005), multiple strokes (OR 3.78, 95% CI 1.6-8, p = 0.002), adjusted Mini-Mental State Examination (MMSEadj) score ≤27 (OR 6.69, 95% CI 3.9-11.6, p = 0.0001), and Fazekas score ≥2 (OR 2.34, 95% CI 1.3-4.2, p = 0.004). The cognitive risk score computed with these 4 factors provided good calibration, discrimination (overoptimism-corrected C = 0.793), and goodness of fit (Hosmer-Lemeshow test p = 0.99). A combination of Rankin Scale score ≥1, cognitive risk score ≥1, and MMSEadj score ≥21 selected 230 (56.9%) of the 404 patients for a comprehensive assessment. This procedure yielded good sensitivity (96.5%) and moderate specificity (43%; positive predictive value 0.66, negative predictive value 0.91) and was more accurate (p ≤ 0.03 for all) than the sole use of screening tests (MMSE or Montréal Cognitive Assessment).
Conclusion: The GRECogVASC cognitive risk score comprises 4 easily documented factors; this procedure helps to identify patients at risk of poststroke NCDs who must therefore undergo a comprehensive assessment.
Clinicaltrialsgov identifier: NCT01339195.
© 2018 American Academy of Neurology.
Figures


References
-
- Barbay M, Taillia H, Nédélec-Ciceri C, et al. ; GRECOG-VASC Study Group. Prevalence of post-stroke neurocognitive disorders using NINDS-CSN, VASCOG criteria and optimized criteria of cognitive deficit. Stroke 2018;49:1141–1147. - PubMed
-
- Barbay M, Diouf M, Roussel M, Godefroy O; GRECOG-VASC Study Group. Prevalence of mild and major post-stroke neurocognitive disorders in hospital-based studies: a systematic review and meta-analysis. Dement Geriatr Cogn Disor (in press 2018). - PubMed
-
- Saposnik G, Cote R, Rochon PA, et al. ; Registry of the Canadian Stroke Network; Stroke Outcome Research Canada (SORCAN) Working Group. Care and outcomes in patients with ischemic stroke with and without preexisting dementia. Neurology 2011;77:1664–1673. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical